(Q43524863)

24 November 2017

title

Omalizumab treatment and exercise capacity in severe asthmatics - results from a pilot study (English)

1 reference

24 November 2017

Omalizumab treatment and exercise capacity in severe asthmatics – Results from a pilot study (English)

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

23 June 2024

0 references

6

Matthias Krüll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739169

23 June 2024

author name string

Christoph Schäper

1

1 reference

24 November 2017

Sven Gläser

2

1 reference

24 November 2017

Annette Gogolka

4

1 reference

24 November 2017

Beate Koch

5

1 reference

24 November 2017

Ralf Ewert

7

1 reference

24 November 2017

Oliver Noga

8

1 reference

24 November 2017

Stephan B. Felix

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739169

23 June 2024

language of work or name

1 reference

24 August 2010

1 reference

full work available at URL

24 November 2017

http://www.resmedjournal.com/article/S0954611110003446/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739169

https://api.elsevier.com/content/article/PII:S0954611110003446?httpAccept=text/xml

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

https://api.elsevier.com/content/article/PII:S0954611110003446?httpAccept=text/plain

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

23 June 2024

1 reference

24 November 2017

volume

105

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

3-7

1 reference

The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma

24 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma

23 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Anti-immunoglobulin E (omalizumab) therapy in allergic asthma

23 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

23 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.

23 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Effects of omalizumab on markers of inflammation in patients with allergic asthma

23 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.

23 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis

23 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years

23 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Development of a ventilatory classification system in patients with heart failure

23 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Impairment of ventilatory efficiency in heart failure: prognostic impact

23 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest

23 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.

23 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Basophil histamine release decreases during omalizumab therapy in allergic asthmatics.

23 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Interpretative strategies for lung function tests

23 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis

23 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

ATS/ACCP Statement on cardiopulmonary exercise testing

23 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Recommendations on the use of exercise testing in clinical practice

23 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study

23 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death.

23 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Assessment of symptoms and exercise capacity in cyanotic patients with congenital heart disease

23 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

23 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

Relationships between fast vital capacity and various timed expiratory capacities

23 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2010.07.023

23 June 2024

Identifiers

1 reference

24 November 2017

1 reference